The effect of l-stepholidine, a novel extract of Chinese herb, on the acquisition, expression, maintenance, and re-acquisition of morphine conditioned place preference in rats

Neuropharmacology

Volumn 52, Issue 2, 2007, Pages 355-361

  Wang, Wei ^a   Zhou, Yuqing ^a   Sun, Jie ^a   Pan, Luanfeng ^a   Kang, Lin ^a   Dai, Zhengze ^a   Yu, Rong ^a   Jin, Guozhang ^b   Ma, Lan ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Conditioned place preference; Dopamine receptor; l Stepholidine; Opiate; Re acquisition

Indexed keywords

ALKALOID; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; MORPHINE; STEPHOLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; LEARNING; MALE; NONHUMAN; OPIATE ADDICTION; PLACE PREFERENCE; PRIORITY JOURNAL; RAT;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BERBERINE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; EXTINCTION, PSYCHOLOGICAL; MALE; MORPHINE; MORPHINE DEPENDENCE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY);

EID: 33846286418     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.08.006     Document Type: Article

References (49)

1. Acquas E., Carboni E., Leone P., and Di Chiara G. SCH 23390 blocks drug conditioned place-preference and place aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine receptor blockade?. Psychopharmacology 99 (1989) 151-155
2. Acquas E., Carboni E., and Di Chiara G. Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur. J. Pharmacol. 193 (1991) 133-134
3. Berger S.P., Mickalian J.D., Reid M.S., Crawford C.A., Delucchi V., and Hall S. Haloperidol antagonism of cue-elicited cocaine craving. Lancet 347 (1996) 504-508
4. Bouton M.E. Context, ambiguity, and unlearning: source of relapse after behavioral extinction. Biol. Psychiatry. 52 (2002) 976-986
5. Cai N. A controlled study on the treatment of tardive dyskinesia using l-stepholidine. Zhonghua Shen Jing Jing Shen Ke Za Zhi 21 (1988) 281-283
6. Caine S.B., and Koob G.F. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J. Pharmacol. Exp. Ther. 270 (1994) 209-218
7. Chen L.J., Guo X., Wang Q.M., and Jin G.Z. Feed-back regulation of presynaptic D2 receptors blocked by l-stepholidine and l-tetrahydropalmatine. Zhongguo Yao Li Xue Bao 13 (1992) 442-445
8. Coffin V.L., Latranyi M.B., and Chipkin R.E. Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors. J. Pharmacol. Exp. Ther. 249 (1989) 769-774
9. Dalton J.C.H., and Vickers G.J. Roberts, Increased self-administration of cocaine following haloperidol: sex-dependent effects of the antiestrogen tamoxifen. Pharmacol. Biochem. Behav. 25 (1986) 497-501
10. De Vries T.J., Schoffelmeer A.N.M., Binnekade R., Raaso H., and Vanderschuren L.J.M.J. Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization. Neuropsychopharmacology 26 (2002) 8-26
11. Dewey S.L., Morgan A.E., Ashby Jr. C.R., Horan B., Kushner S.A., Logan J., Volkow N.D., Fowler J.S., Gardener E.L., and Brodie J.D. A novel strategy for the treatment of cocaine addiction. Synapse 30 (1998) 119-129
12. Di Chiara G., and Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244 (1988) 1067-1080
13. Dong Z.J., Guo X., Chen L.J., Han Y.F., and Jin G.Z. Dual actions of (-)-stepholidine on the dopamine receptor mediated adenylate cyclase activity in rat corpus striatum. Life Sci. 61 (1997) 465-472
14. Everitt B.J., Dickinson A., and Robbins T.W. The neuropsychological basis of addictive behavior. Brain Res. Rev. 36 (2001) 129-138
15. Grech D.M., Spealman R.D., and Bergman J. Self-administration of D1 receptor agonists by squirrel monkeys. Psychopharmacology (Berl.) 125 (1996) 97-104
16. Haney M., Collins E.D., Ward A.S., Foltin R.W., and Fischman M.W. Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology (Berl.) 143 (1999) 102-110
17. Hoffman D.C., and Beninger R.J. The effects of selective dopamine D1 or D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats. Pharmacol. Biochem. Behav. 33 (1989) 273-279
18. Huang K.X., and Jin G.Z. The antagonistic effects of tetrahydroprotoberberines on dopamine receptors: electrophysiological studies. Sci. China [B] 36 (1992) 688-696
19. Jin G.Z., and Sun B.C. l-Stepholidine and its analogues act on brain dopamine receptors. Prog. Nat. Sci. 5 (1995) 55-63
20. Jin G.Z., Zhu Z.T., and Fu Y. (-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions. Trends Pharmacol Sci. 23 (2002) 4-7
21. Khroyan T.V., Barrett- Larimore R.L., Rowlett J.K., and Spealman R.D. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J. Pharmacol. Exp. Ther. 294 (2000) 680-687
22. Koob G.F., and Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science (Wash. DC) 242 (1988) 715-723
23. Leone P., and Di Chiara G. Blockade of D-1 receptors by SCH23390 antagonizes morphine- and amphetamine-induced place preference conditioning. Eur. J. Pharmacol. 135 (1987) 51-54
24. Liu Z.H., Jin W.Q., Zhang H.P., Chen X.J., and Jin G.Z. Suppression of morphine-induced conditioned place preference by l-12-chloroscoulerine, a novel dopamine receptor ligand. Pharmacol. Biochem. Behav. 75 (2003) 289-294
25. Lu L., Su W.J., Yue W., Ge X., Su F., Pei G., and Ma L. Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor. Life Sci. 69 (2001) 37-46
26. Lu L., Xu N.J., Ge V., Yue W., Su W.J., Pei G., and Ma L. Reactivation of morphine conditioned place preference by drug priming: role of environmental cues and sensitization. Psychopharmacology (Berl.) 159 (2002) 125-132
27. Maldonado R., Saiardi A., Valverde A.O., Samad T.A., Roques B.P., and Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388 (1997) 586-589
28. Manzanedo C., Aguilar M.A., Rodriguez-Arias M., and Minarro J. Effect of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav. Brain Res. 121 (2001) 189-197
29. McBride W.J., Murphy J.M., and Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav. Brain Res. 101 (1999) 129-152
30. Mo Y.Q., Jin X.L., Chen Y.T., Jin G.Z., and Shi W.X. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol. Neuropsychopharmacology 30 (2005) 261-267
31. Nazarian A., Russo S.J., Festa E.D., Kraish M., and Quinonee-Jenab V. The role of D1 and D2 receptors in the cocaine conditioned place preference of male and female rats. Brain Res. Bull. 63 (2004) 295-299
32. Olmstead M.C., and Franklin K.B. The development of a conditioned place preference to morphine: effects of lesions of various CNS sites. Behav. Neurosci. 111 (1997) 1313-1323
33. Roberts D.C.S., Loh E.A., and Vickers G. Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment. Psychopharmacology 97 (1989) 535-538
34. Self D.W., Barnhart W.J., Lehman D.A., and Nestler E.J. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science 271 (1996) 1586-1589
35. Shaham Y., and Stewart J. Effects of opioid and dopamine receptor antagonists on relapse induced by stress and reexposure to heroin in rats. Psychopharmacology 125 (1996) 385-391
36. Shippenberg T.S., and Hertz A. Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists. Eur. J. Pharmacol. 151 (1988) 233-242
37. Smith J.W., Fetsko L.A., Xu R., and Wang Y. Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning. Neuroscience 113 (2002) 755-765
38. Stolerman I. Drugs of abuse: behavioral principle, methods and terms. Trends Pharmacol. Sci. 13 (1992) 170-176
39. Sun B.C., and Jin G.Z. Effects of (-)-stepholidine on firing activity of dopamine neurons in ventral tegmental area of rats. Acta Pharmacol. Sin. 13 (1992) 395-399
40. Suzuki T., and Misawa M. Sertindole antagonizes morphine-, cocaine-, and methamphetamine-induced place preference in the rat. Life Sci. 57 (1995) 1277-1284
41. Tang Y.L., Zhao D., Zhao C.Z., and Cubells J.F. Opiate addiction in China: current situation and treatments. Addiction 101 (2006) 657-665
42. Vorel S.R., Ashby Jr. C.R., Paul M., and Liu X.H. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J. Neurosci. 22 (2002) 9595-9603
43. Wise R.A., and Bozarth M.A. Brain mechanisms of drug reward and euphoria. Psychiatr. Med. 3 (1985) 445-460
44. Wise R.A. Neurobiology of addiction. Curr. Opin. Neurobiol. 6 (1996) 243-251
45. Wise R.A. Drug-activation of brain reward pathways. Drug Alcohol Depend. 51 (1998) 13-22
46. Wise R.A. Brain reward circuitry: insights unsensed incentives. Neuron 36 (2002) 229-240
47. Wu D.C., Xing X.Z., Wang W.A., Wang H.H., Wang X.Y., Cong Z., and Jin G.Z. A double blind comparison trial of 1-stepholidine and perphenazine in treatment of schizophrenia. Chin. J. New Drugs Clin. 22 (2003) 155-160
48. Xu S.X., Yu L.P., Han Y.R., Chen Y., and Jin G.Z. Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain. Acta Pharmacol. Sin. 10 (1989) 104-110
49. Zou L.L., Liu J., and Jin G.Z. Involvement of receptor reserve in D1 agonistic action of (-)-stepholidine in lesioned rats. Biochem. Pharmacol. 54 (1997) 233-240